Fig 2. Baseline neopterin in relation to evolution of CD4 cell count at completion of ATT subdivided into two groups; No increase (CD4 cell count ≤50 cells/mm³ or unchanged CD4 cell count, ± 50 cells/mm³ after 6 months ATT), or increase (CD4 ≥50 cells/mm³ after 6 months ATT).

Graph A displays HIV-patients (n = 85 of whom 58 had an increase in CD4 cell count). Baseline median CD4 cell count for those with increasing CD4 cell count was 405 cells/mm³ and 496 cells/mm³ for those without increasing CD4 cell count (n = 27). Graph B displays HIV+ patients who did not start ART (n = 43 of whom 22 had an increase in CD4 cell count). Baseline median CD4 cell count for those with increasing CD4 cell count was 255 cells/mm³ and 411 cells/mm³ for those without increasing CD4 cell count (n = 21).